📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood-Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2. (2022)

First Author: Liu X

Attributed to: Understanding Signalling Pathways Mutated in Inherited Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/jacs.2c05499

PubMed Identifier: 36007011

Publication URI: http://europepmc.org/abstract/MED/36007011

Type: Journal Article/Review

Volume: 144

Parent Publication: Journal of the American Chemical Society

Issue: 37

ISSN: 0002-7863